SS Innovations completes intercontinental robotic cardiac telesurgery

SS Innovations International, a developer of surgical robotic technologies that aims to make healthcare via robotic surgery affordable for and accessible to a global population, announced that the company’s chairman of the board and CEO, Dr. Sudhir Srivastava, M.D., successfully completed the world’s first intercontinental robotic cardiac telesurgery.

The surgery was performed in mid-July, 2025, utilizing the company’s SSi Mantra 3 surgical robotic system.

Telesurgery details

Dr. Srivastava performed the cardiac procedure, a robotic atrial septal defect closure, remotely from the global headquarters of the Institute of Research Against Digestive Cancer (IRCAD) in Strasbourg, France, during the Society of Robotic Surgery (SRS) Annual Meeting.

The procedure was conducted across a transmission distance of more than 4,000 miles to the operating room at the Sri Aurobindo Institute of Medical Sciences (SAIMS) in Indore, India.

Patient-side support in Indore was coordinated by:

• Dr. Lalit Malik, Chief of Cardiac Surgery, Manipal Hospital, Jaipur;
• Dr. Ram Krishna Shukla, Cardiologist, SAIMS, Indore;
• Dr. Bipin Arya, Anesthesiologist, SAIMS, Indore; and
• the SS Innovations and SAIMS teams.

The live telesurgery was moderated by robotic cardiac surgeon Dr. Husam H. Balkhy, M.D., president of the International Society for Minimally Invasive Cardiothoracic Surgery (ISMICS) and professor of surgery and director of robotic and minimally invasive cardiac surgery at the University of Chicago Medicine.

“I would like to extend my gratitude to Dr. Vipul Patel, M.D., F.A.C.S., chairman of the Society of Robotic Surgery for this opportunity at the SRS 2025 Conference, Dr. Mohit Bhandari, the IRCAD India team and the entire SS Innovations team whose dedication and innovation made the world’s first intercontinental robotic cardiac telesurgery possible,” Dr. Srivastava said. “This historic achievement not only demonstrates the advanced capabilities of our SSi Mantra 3 surgical robotic system, but also further paves the way for redefining and democratizing global delivery of complex cardiac care, especially in regions with limited access to surgical expertise.”

Together, the team successfully completed the surgery without any technical issues and with an imperceptible latency, precision and seamless robotic control. SS Innovations said these deails showcase the robustness of the SSi Mantra 3 and its telesurgery architecture.

SSI Mantra used on over 5,000 surgeries

SS Innovations said its SSi Mantra surgical robotic technology platform - with its cutting edge telesurgery capabilities - addresses traditional obstacles related to travel, time, cost and surgical accessibility, creating a more efficient and equitable medical standard for both patients and surgeons.

To date, the company said that 35 telesurgeries, including 10 cardiac procedures, and a total of 250 cardiac procedures have been successfully completed utilizing the SSi Mantra surgical robotic system. Cardiac-related procedures often rank among the most difficult operations to perform, which SS Innovations said is a testament to SSi Mantra’s capabilities in both telesurgery and complex soft-tissue surgeries in general.

Additionally, over 5,000 multi-specialty surgeries have been successfully carried out with the SSi Mantra system without any device-related adverse events.